Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,819.60
(
-0.52%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.56
(
-1.19%
)
Bitcoin
75,228.52
(
1.85%
)
News Focus
News Focus
Post# of 158400
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

YoungBuckTrader

Send PM Follow Ignore
Followers 75
Posts 1203
Boards Moderated 0
Alias Born 10/23/2012

YoungBuckTrader

Re: None

Tuesday, 08/20/2013 9:04:55 AM

Tuesday, August 20, 2013 9:04:55 AM

Post# of 158400
If we get IND approved, Orphan Designation is a given. PSTI got Orphan Designation once they were approved for their treatment Aplastic Anemia. They also received over 5million from the Israeli government. Also they are noticing the wide range of diseases their Aplastic anemia, PLX can treat. BMSN will follow this path, and it will be known that Hemaxellerate will be used on multiple diseases related to hematology/rbc deficiencies. Imo
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today